Christopher P. Molineaux
Lead Independent DirectorMr. Christopher P. Molineaux is Member of Advisory Board of Philadelphia Convention & Visitors Bureau. He had been Independent Chairman of Aclaris Therapeutics, Inc. since June 2019 until January 01, 2023 and serves as its Lead Independent Director since January 01, 2023. Mr. Molineaux serves as the President, Chief Executive Officer and Director of The Pennsylvania Biotechnology Association. Mr. Molineaux oversees the strategic direction for the association, assuring that Life Sciences Pennsylvania continues to be the catalyst that makes Pennsylvania the top location for life sciences companies. He serves as President of Life Sciences Pennsylvania (formerly known as Pennsylvania Bio). He serves as the Chief Advocate and Spokesman for the biotechnology, device, diagnostic, pharmaceutical, research organizations and support network that call Pennsylvania home. Mr. Molineaux has experience in the bio-pharmaceutical and health care industries, with front-line experience in developing and executing strategies to navigate a shifting economic and political environment. He joined Life Sciences Pennsylvania in 2009 as senior vice president for membership services, responsible for managing and enhancing the relationship between the association and member companies and for developing and executing the strategic membership plan for the association’s continued growth. Prior to joining Life Sciences Pennsylvania in September 2009, Mr. Molineaux served as worldwide Vice President of pharmaceutical communication and public affairs for Johnson & Johnson. He began his Johnson & Johnson career as Vice President of Corporate Communications at Centocor in Malvern and served as Vice President for communications of its global Biotechnology, Immunology & Oncology (B.I.O.) business unit. In his time with Johnson & Johnson, he served on the leadership teams and management boards for each division for which he worked. He helped to promote its advocacy agenda in the US and abroad, guided the communication of its value to government agencies globally and worked to build public and investor awareness and understanding around its product and pipeline portfolio. Mr. Molineaux previously served as Vice President of public affairs at the Pharmaceutical Research and Manufacturers Association (PhRMA), where he worked on many critical industry issues, including the passage of a meaningful prescription drug benefit for Medicare beneficiaries (Medicare part D). He serves as Independent Director of Aclaris Therapeutics, Inc. from January 2014. He serves as a Director of The Pennsylvania Biotechnology Association. Prior to this, he worked at the Blue Cross and Blue Shield Association developing public awareness and education strategies related to commercial and government payer systems and helping to reposition the Blue Cross and Blue Shield system of health care plans at a time when business organizations sought solutions to lowering health care costs. Mr. Molineaux also worked as a public affairs executive for both the federal Departments of Health and Human Services (HHS) and Agriculture and on the White House staff of President. He received a B.A. degree from the College of the Holy Cross.
Positions
- Company NameAclaris Therapeutics, Inc.Stock CodeACRSPositionLead Independent Director
